As we reflect on 2024, I am proud to share the remarkable progress Atossa Therapeutics has made in advancing our mission to address significant unmet needs in breast cancer prevention and treatment.
The Nathan Yip Foundation announced recently that rural Colorado teachers can submit a letter of inquiry by Feb. 14 for consideration of a grant that can be used in the 2025-2026 school year.
Atara Biotherapeutics Inc. received a complete response letter from the U.S. FDA for its lead product Ebvallo (tabelecleucel), a breakthrough therapy for Epstein-Barr virus positive post-transplant ...